CA
INDV icon

Cliff Asness’s Indivior Pharmaceuticals INDV Stock Holding History

Cliff Asness’s Portfolio INDV Stock Details INDV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.77M Sell
213,851
-90,351
-30% -$3.28M ﹤0.01% 1654
2026
Q1 		$9.27M Sell
304,202
-77,960
-20% -$2.57M ﹤0.01% 1376
2025
Q4 		$13.7M Buy
382,162
+367,715
+2,545% +$11.2M 0.01% 1079
2025
Q3 		$348K Buy
+14,447
New +$302K ﹤0.01% 3011

Other funds holding INDV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
OCM
Oaktree Capital Management Los Angeles, California $7.21B AUM 45.97% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TSC
Two Seas Capital Rye, New York $5.05B AUM 164.99% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cliff Asness's INDV Position: Q2 2026 in Review

Cliff Asness reduced its Indivior Pharmaceuticals (INDV) stake by 30% in Q2 2026, selling an estimated $3.28M and leaving 213,851 shares worth $8.77M. The position accounts for ﹤0.01% of the portfolio, ranked #1654.

Cliff Asness first reported a position in INDV in Q3 2025 and has held it in 4 quarters since. The position peaked at $13.7M in Q4 2025. 336 funds tracked by Wall St. Rank hold INDV as of Q2 2026.

  • Cliff Asness held 213,851 shares of Indivior Pharmaceuticals worth $8.77M as of Q2 2026.
  • Cliff Asness sold 90,351 Indivior Pharmaceuticals shares in Q2 2026, an estimated $3.28M.
  • Indivior Pharmaceuticals made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #1654 holding.
  • Cliff Asness first reported a position in Indivior Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Cliff Asness's Indivior Pharmaceuticals position peaked at $13.7M in Q4 2025.
  • 336 funds tracked by Wall St. Rank held Indivior Pharmaceuticals as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.